Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

PFE

Pfizer (PFE)

Pfizer Inc
일자:
정렬 기준:
 검색 관련기사 보기:NYSE:PFE
일자시간출처헤드라인심볼기업
2024/07/1706:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
2024/07/1706:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
2024/07/1706:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
2024/07/1302:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
2024/07/1302:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
2024/07/1302:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
2024/07/1219:28IH Market NewsEricsson Reports 14% Profit Increase, UBS Downgrades Tesla Shares, Ozempic Linked to Reduced Dementia RiskNYSE:PFEPfizer Inc
2024/07/1119:45Business WirePfizer Advances Development of Once-Daily Formulation of Oral GLP-1 Receptor Agonist DanuglipronNYSE:PFEPfizer Inc
2024/07/1105:11Edgar (US Regulatory)Form 8-K - Current reportNYSE:PFEPfizer Inc
2024/07/1019:42IH Market NewsMicrosoft and Apple Exit OpenAI Board, TSMC Exceeds Forecasts with Record Revenue, and Other Key UpdatesNYSE:PFEPfizer Inc
2024/07/0919:45Business WirePfizer to Launch Process to Identify a Successor for Dr. Mikael Dolsten, Chief Scientific Officer and President, Pfizer Research & DevelopmentNYSE:PFEPfizer Inc
2024/07/0119:45Business WireCyrus Taraporevala Elected to Pfizer’s Board of DirectorsNYSE:PFEPfizer Inc
2024/06/2723:30Business WirePfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European UnionNYSE:PFEPfizer Inc
2024/06/2705:30Business WirePfizer Declares Third-Quarter 2024 DividendNYSE:PFEPfizer Inc
2024/06/1823:00Business WirePfizer Invites Public to View and Listen to Webcast of July 30 Conference Call with AnalystsNYSE:PFEPfizer Inc
2024/06/1820:02IH Market NewsFisker Files for Bankruptcy, Chegg Stocks Rise on 23% Workforce Reduction, and MoreNYSE:PFEPfizer Inc
2024/06/1810:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
2024/06/1810:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
2024/06/1420:21IH Market NewsAdobe Soars 15% Pre-Market; Visa and Mastercard Encounter Hurdles in $30 Billion Agreement, and MoreNYSE:PFEPfizer Inc
2024/06/1416:00Business WireELREXFIO™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory Multiple MyelomaNYSE:PFEPfizer Inc
2024/06/1305:30Business WirePfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with Duchenne Muscular DystrophyNYSE:PFEPfizer Inc
2024/06/1203:43Edgar (US Regulatory)Form 11-K - Annual report of employee stock purchase, savings and similar plansNYSE:PFEPfizer Inc
2024/06/1203:39Edgar (US Regulatory)Form 11-K - Annual report of employee stock purchase, savings and similar plansNYSE:PFEPfizer Inc
2024/06/1020:29IH Market NewsApple Showcases AI at WWDC 2024, Nvidia Stock Split Starts Today, and More NewsNYSE:PFEPfizer Inc
2024/06/0605:05GlobeNewswire Inc.Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608NYSE:PFEPfizer Inc
2024/06/0506:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
2024/06/0506:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
2024/06/0407:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
2024/06/0323:00Business WirePfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare ConferenceNYSE:PFEPfizer Inc
2024/06/0121:00Business WireTakeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin LymphomaNYSE:PFEPfizer Inc
 검색 관련기사 보기:NYSE:PFE